Drug-Gene Testing: Key to Safer Cancer Treatment

Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.

Read More

How Are Hospitals Bracing for Tariffs?

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial…

Read More

This week in Pharmaceutical policy under President Trump

Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…

Read More

On Autism, Kennedy Turns Against Science and Reality

During his first news conference as Health and Human Services secretary, Robert F. Kennedy Jr. on April 16 ticked off things he thinks kids with autism will never do, including paying taxes, holding a job, and going on a date. Kennedy’s comments go against science and reality.  This slide presentation first appeared on KFF Health…

Read More

Why One Healthcare Founder Never Took Venture Capital

Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…

Read More

Medical Device Right to Repair is the Wrong Approach

How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?” The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.

Read More